Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,723.50
Bid: 2,046.00
Ask: 1,364.00
Change: 18.50 (1.09%)
Spread: -682.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: GSK, Sainsbury's, BT, Imagination Technologies

Sun, 21st Feb 2016 17:23

(ShareCast News) - Financial institutions in the City of London are fairly pleased with David Cameron's agreement with the European Union ahead of June's referendum as it looks to have secured the Square Mile from excessive further Brussels red tape. A potentially painful sticking point has been avoided as financial freedoms are covered in the first section of the agreement, the Sunday Times said, with countries outside the eurozone have been given the right to determine how their banks and other big institutions are regulated.Sainsbury's bid for Argos owner Home Retail Group has been thrown into turmoil by a last-minute £1.4bn bid by South Africa's Steinhoff International. Steinhoff, which is 17% owned by billionaire Iceland and New Look owner Christo Wiese, has approached HRG with a cash offer believed to be worth 175p a share, the Mail on Sunday reported, which is above Sainsbury's 160p mixture of cash and shares that was due to be formalised on Tuesday evening.The Sunday Times reported that Sainsbury's could seek an extension to the deadline as it battles Steinhoff, which owns Bensons for Beds and Harveys in Britain, though the value of the supermarket group's bid has risen to 167p as its shares have appreciated. Bernstein analyst Bruno Monteyne said he expected Sainsbury's to match the Steinhoff bid.Revenues from GlaxoSmithKline's biggest-selling drug, asthma treatment Advair, will be devastated by two rival, generic treatments in development by its rivals. Competitor Mylan has now submitted an application for its US Food and Drug Administration, the Sunday Times reported, with the regulator able to approve the drug early next year.BT will not be forced by regulator Ofcom to sell its Openreach infrastructure arm, the Mail on Sunday said. But the telecoms giant is expected to propose a greater separation of Openreach from the rest of the company, including the possibility of a separate board and a new corporate structure for Openreach or more rules to reduce the influence of BT group management over its strategy.Smartphone chip designer Imagination Technologies has held talks with potential US suitor Rambus about a potential £850m bid. The Nasdaq-listed company was rejected when it made an informal bid last year, inside sources told the Sunday Times. The auction for a majority stake of National Grid's £11bn gas pipeline arm is set to kick off in late spring, with jostling suitors including a group made up of Canada's Borealis Infrastructure, Wren House, a division of Kuwait's sovereign wealth fund, and the Universities Superannuation Scheme.Banks remain concerned that one their most popular means of raising money, via the contingent convertible or CoCo bond market, has dried up. European lenders had planned to issue €40bn of bonds this year, the Sunday Telegraph reported, but the dive in CoCo prices and only partial rebound has seen no issuances in 2016, leaving a big question market over the industry.Taxpayer owned banks Royal Bank of Scotland and Lloyds Banking Group are both expected to unveil combined closures of more than 400 bank branches this week alongside their results. Squashed by low interest rates and high bills for PPI misselling, the pair are forecast to announce tougher cost cutting in coming years, the Sunday Telegraph said, with only political pressures preventing much larger cuts.The two banks' results will see around £10bn paid out in dividends and bonuses, the Mail on Sunday said. This would result in Lloyds paying the treasury £180m from its 9% stake, while an RBS' dividend is still being withheld.Permission needs to be gained from the Bank of England, with Lloyds chief executive Antonio Horta-Osorio aiming to pay about £1.5bn, or 2p a share, in an ordinary dividend and £500m or more in a one-off special dividend. A big payout would be politically charged because of the £20bn bailout the bank received at the height of the financial crisis, the Sunday Times noted.Going the other way, like many of its peers, mining giant BHP Billiton is expected to reduce its ,massive $6.6bn (£4.6bn) payout by about 50%. The Sunday Times noted that as well as the plunging prices of commodities, BHP faces billions of dollars in damages after the Samarco dam burst last year.Pearson is expected to write down the value of its overseas divisions to such an extent that it would have slipped into a annual loss had it not been for the sale of the Economist last year, the Sunday Times said. Results are due on Friday.Write-downs will also hit Ladbrokes and William Hill as their annual results are hammered by the first full year of paying the point-of-consumption tax, a 15% levy on online gambling profits and greater regulation of fixed odds betting terminals taxed at 25% and now restricted to four per shop. Ladbrokes will report the first statutory loss in its history, the Sunday Times said, after taking a huge writedown on the value of its ageing betting shops and paying an extra £40m in taxes last year, while Hills is forecast to endure profits plummeting 22%.Gambling software company Playtech is pondering a £250m bid for software developer OpenBet and another for Canada's Amaya. The FTSE 250 company has been under pressure to spend or return its £600m cash pile, the Sunday Times reported, with the potential warchest expanding to £800m if stakes it owns in its rivals are sold.Clothing retailer Joules has hired advisers for a London flotation that could value the business, which is backed by Lloyds' private equity arm LDC, at more than £150m. The Sunday Telegraph said a float was expected in April or May, run by brokers Librium and Peel Hunt.A new, London-listed shell company will be created to buy the football pools from current owner Sportech for roughly £100m. Sportech has granted Hogg preferred bidder status ahead of other suitors, the Sunday Times reported, which had been battling AIM-listed Netplay until late last year.Chancellor George Osborne is plotting a £4bn "tax bombshell" that would hit hundreds of thousands of people saving for their pensions by abolishing the tax-free lump sum, according to a former pensions minister. Currently people can access 25% of their pension pots tax-free in a single lump sum when they reach 55 but Osborne would like to scrap all tax relief on pension contributions and replace it with an Isa-style system, the Sunday Times reported.
More News
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.